Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

2003 • 25,662 citations

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2001 • 24,089 citations

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

2002 • 18,132 citations

Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report

1998 • 9,277 citations

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

2000 • 8,604 citations

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

1998 • 7,971 citations

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

2005 • 4,969 citations

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

2007 • 4,614 citations

Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery

2004 • 4,334 citations

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

2005 • 4,040 citations

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1995 • 3,109 citations

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

2006 • 2,850 citations

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

2005 • 2,476 citations

Who Would Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset Diabetes Mellitus

1995 • 2,296 citations

Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes

2006 • 2,229 citations

Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

2005 • 2,039 citations

Thiazolidinediones

2004 • 1,755 citations

Metformin

1996 • 1,637 citations

Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance

2003 • 1,628 citations

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

2005 • 1,541 citations

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

2004 • 1,329 citations

Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus

1995 • 1,328 citations

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

1999 • 1,281 citations

Pioglitazone and Risk of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

2007 • 1,240 citations

The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes Mellitus

1993 • 1,215 citations

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

2005 • 1,170 citations

Oral Antihyperglycemic Therapy for Type 2 Diabetes

2002 • 1,044 citations

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)

2001 • 1,027 citations

Association of Hemoglobin A_1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk

2004 • 983 citations

The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial

1995 • 973 citations

Standards of Medical Care in Diabetes–2006

2006 • 963 citations

Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus

2003 • 810 citations

Long-term Risk of Cardiovascular Events With Rosiglitazone

2007 • 808 citations

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

2005 • 804 citations

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

2005 • 799 citations

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

2007 • 762 citations

Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes

2003 • 739 citations

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

2007 • 692 citations

Standards of Medical Care in Diabetes

2004 • 676 citations

A desktop guide to Type 2 diabetes mellitus

1999 • 661 citations

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

2000 • 592 citations

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

2004 • 578 citations

Initiating Insulin Therapy in Type 2 Diabetes

2005 • 570 citations

Impact of Intensive Lifestyle and Metformin Therapy on Cardiovascular Disease Risk Factors in the Diabetes Prevention Program

2005 • 561 citations

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

2000 • 547 citations

Glycosylated Hemoglobin Predicts the Incidence and Progression of Diabetic Retinopathy

1988 • 506 citations

Thiazolidinedione Use and Bone Loss in Older Diabetic Adults

2006 • 499 citations

Basal Insulin Therapy in Type 2 Diabetes

2001 • 491 citations

Glycosylated Hemoglobin and the Risk of Microalbuminuria in Patients with Insulin-Dependent Diabetes Mellitus

1995 • 460 citations

Regression of Carotid Atherosclerosis by Control of Postprandial Hyperglycemia in Type 2 Diabetes Mellitus

2004 • 447 citations

Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus

1999 • 445 citations

Hypoglycemia in Type 2 Diabetes

2005 • 432 citations

Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes

2005 • 417 citations

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence

2001 • 410 citations

Sulfonylureas in NIDDM

1992 • 409 citations

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy

2006 • 408 citations

Should minimal blood glucose variability become the gold standard of glycemic control?

2005 • 395 citations

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes

2006 • 372 citations

Self-Monitoring of Blood Glucose in Patients With Type 2 Diabetes Who Are Not Using Insulin

2005 • 371 citations

Initial Management of Glycemia in Type 2 Diabetes Mellitus

2002 • 368 citations

Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial

1995 • 365 citations

The national glycohemoglobin standardization program: a five-year progress report.

2001 • 344 citations

Hypoglycemia in Patients With Type 2 Diabetes Mellitus

2001 • 333 citations

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

2005 • 315 citations

Pramlintide as an Adjunct to Insulin Therapy Improves Long-Term Glycemic and Weight Control in Patients With Type 2 Diabetes

2003 • 293 citations

Glycemic Control and Coronary Heart Disease Risk in Persons With and Without Diabetes

2005 • 292 citations

Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide

2001 • 278 citations

Efficacy and Safety of Inhaled Insulin (Exubera) Compared With Subcutaneous Insulin Therapy in Patients With Type 2 Diabetes

2004 • 269 citations

A Prospective, Randomized Comparison of the Metabolic Effects of Pioglitazone or Rosiglitazone in Patients With Type 2 Diabetes Who Were Previously Treated With Troglitazone

2002 • 254 citations

Glucose Control and the Renal and Retinal Complications of Insulin-dependent Diabetes

1989 • 249 citations

Biologic actions and therapeutic potential of the proglucagon-derived peptides

2005 • 227 citations

Amylin Agonists: A Novel Approach in the Treatment of Diabetes

2004 • 226 citations

Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial

2002 • 211 citations

Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus

2001 • 205 citations

Insulin-sensitive and insulin-insensitive types of diabetes mellitus.

1939 • 188 citations

Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated With Improved Outcomes?

2002 • 182 citations

Repaglinide Versus Nateglinide Monotherapy

2004 • 178 citations

A Real-World Approach to Insulin Therapy in Primary Care Practice

2005 • 175 citations

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus

2001 • 168 citations

Oral Antihyperglycemic Therapy for Type 2 Diabetes

2017 • 166 citations

Inhaled Insulin Improves Glycemic Control When Substituted for or Added to Oral Combination Therapy in Type 2 Diabetes

2005 • 161 citations

Epidemiological Correlates of NIDDM in Hispanics, Whites, and Blacks in the u.s. Population

1991 • 160 citations

Insulin Glulisine Provides Improved Glycemic Control in Patients With Type 2 Diabetes

2004 • 155 citations

Is HbA1c Affected by Glycemic Instability?

2003 • 150 citations

Laparoscopic Gastric Banding Prevents Type 2 Diabetes and Arterial Hypertension and Induces Their Remission in Morbid Obesity

2005 • 133 citations

Glibenclamide vs Gliclazide in Type 2 Diabetes of the Elderly

1994 • 123 citations

Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs

2003 • 120 citations

Insulin Use in NIDDM

1990 • 118 citations

PRESERVE-β

2005 • 117 citations

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy

1988 • 110 citations

Maturity onset diabetes mellitus: response to intensive dietary management.

1975 • 105 citations

Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia.

2000 • 102 citations

Current Therapeutic Options in Type 2 Diabetes Mellitus: A Practical Approach

2003 • 95 citations

Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients

1998 • 90 citations

Alcohol and the risk of myocardial infarction

2001 • 90 citations

Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: A 24-week, multicenter, randomized, double-blind, parallel-group study

2005 • 75 citations

Pharmacology of the Meglitinide Analogs

2003 • 74 citations

Improved Glycemic Control Without Weight Gain Using Triple Therapy in Type 2 Diabetes

2004 • 72 citations

Glyburide or Insulin for Metabolic Control in Non-Insulin-Dependent Diabetes Mellitus

1988 • 68 citations

ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline

2005 • 61 citations

Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data

2004 • 60 citations

Glucose control and the renal and retinal complications of insulin-dependent diabetes

1989 • 44 citations

Basic Approach to Managing Hyperglycemia for the Nonendocrinologist

2005 • 9 citations

Compared with repaglinide sulphonylurea treatment in type 2 diabetes is associated with a 2.5-fold increase in symptomatic hypoglycaemia with blood glucose levels < 2.5 mmol/l

2000 • 5 citations

Deleted Work

1955 • 0 citations